Related references
Note: Only part of the references are listed.Impact of COVID-19 on global HCV elimination efforts
Sarah Blach et al.
JOURNAL OF HEPATOLOGY (2021)
Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in Myanmar
Lara K. Marquez et al.
BMJ GLOBAL HEALTH (2021)
Effects and cost of different strategies to eliminate hepatitis C virus transmission in Pakistan: a modelling analysis
Aaron G Lim et al.
Lancet Global Health (2020)
Screening and Treatment Program to Eliminate Hepatitis C in Egypt
Imam Waked et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A model of the economic benefits of global hepatitis C elimination: an investment case
Nick Scott et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Global hepatitis C elimination: an investment framework
Alisa Pedrana et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Progress on scaling up testing and treatment for hepatitis C elimination in Punjab, Pakistan: Hepatitis prevention and treatment program
Ammara Naveed et al.
JOURNAL OF HEPATOLOGY (2019)
Characterization of the hepatitis C virus epidemic in Pakistan
Sarwat Mahmud et al.
BMC INFECTIOUS DISEASES (2019)
Prevalence of tuberculosis, HIV/AIDS, and hepatitis; in a prison of Balochistan: a cross-sectional survey
Ahmad Wali et al.
BMC PUBLIC HEALTH (2019)
Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan
Jagpreet Chhatwal et al.
JAMA NETWORK OPEN (2019)
Impact of ledipasvir/sofosbuvir on the work productivity of genotype 1 chronic hepatitis C patients in Asia
Z. M. Younossi et al.
JOURNAL OF VIRAL HEPATITIS (2018)
Aiming at the Global Elimination of Viral Hepatitis: Challenges Along the Care Continuum
Alastair Heffernan et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving elimination
Aaron G. Lim et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2018)
The epidemiology of hepatitis C virus in Pakistan: systematic review and meta-analyses
Zaina Al Kanaani et al.
ROYAL SOCIETY OPEN SCIENCE (2018)
Pathways to ensure universal and affordable access to hepatitis C treatment
Caitlin H. Douglass et al.
BMC MEDICINE (2018)
Real-world impact of direct acting antiviral therapy on health-related quality of life in HIV/Hepatitis C co-infected individuals
Sahar Saeed et al.
JOURNAL OF VIRAL HEPATITIS (2018)
Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures
H. Qureshi et al.
EASTERN MEDITERRANEAN HEALTH JOURNAL (2018)
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Hmwe Hmwe Kyu et al.
LANCET (2018)
Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data
Jessica Ochalek et al.
BMJ GLOBAL HEALTH (2018)
Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis
Lucy Platt et al.
ADDICTION (2018)
Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness model
Nick Scott et al.
GUT (2017)
Negotiating better discounts for DAA therapy is critical to achieve HCV elimination by 2030
Gregory J. Dore et al.
JOURNAL OF HEPATOLOGY (2017)
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review
Louisa Degenhardt et al.
LANCET GLOBAL HEALTH (2017)
Management of chronic Hepatitis C at a primary health clinic in the high-burden context of Karachi, Pakistan
Yuely A. Capileno et al.
PLOS ONE (2017)
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Sarah Blach et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countries
Z. Younossi et al.
JOURNAL OF VIRAL HEPATITIS (2016)
Requirements for global elimination of hepatitis B: a modelling study
Shevanthi Nayagam et al.
LANCET INFECTIOUS DISEASES (2016)
Disability weights for the Global Burden of Disease 2013 study
Joshua A. Salomon et al.
LANCET GLOBAL HEALTH (2015)
Cost-effectiveness model for hepatitis C screening and treatment: Implications for Egypt and other countries with high prevalence
David D. Kim et al.
GLOBAL PUBLIC HEALTH (2015)
Modeling the impact of early antiretroviral therapy for adults coinfected with HIV and hepatitis B or C in South Africa
Natasha K. Martin et al.
AIDS (2014)
Population-attributable estimates for risk factors associated with hepatitis B and C: policy implications for Pakistan and other South Asian countries
Bilal Ahmed et al.
HEPATOLOGY INTERNATIONAL (2013)
The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities
Marco daCosta DiBonaventura et al.
JOURNAL OF MEDICAL ECONOMICS (2011)
The Impact of Hepatitis C Virus Infection on Work Absence, Productivity, and Healthcare Benefit Costs
Jun Su et al.
HEPATOLOGY (2010)
Safer injections following a new national medicine policy in the public sector, Burkina Faso 1995-2000
S Logez et al.
BMC PUBLIC HEALTH (2005)
Share Paper
